16
Tue, Apr
43 New Articles

SSK&W Advises Open Innovation by YouNick Mint on nCage Therapeutics Investment

SSK&W Advises Open Innovation by YouNick Mint on nCage Therapeutics Investment

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

SSK&W has advised Open Innovation by YouNick Mint and its co-investors on their investment in nCage Therapeutics. Krzysztof Rozko i Wspolnicy reportedly advised nCage Therapeutics.

Open Innovation by YouNick Mint is a fund managed by business practitioners in healthcare and industry 4.0. The size of the fund is PLN 57 million.

nCage Therapeutics is a biopharmaceutical company developing synthetic virus-like particle platform technology to develop vaccines against infectious diseases and deliver drug conjugates and second-generation antibodies.

According to SSK&W, "the funds from the investment will be used to develop [nCage Therapeutics'] own innovative synthetic platform based on virus-like particles, which in groundbreaking experiments on animals has demonstrated its possibility of being used to produce both new generation vaccines and innovative drug carriers."

The SSK&W team included Partner Szymon Syp and Associate Katarzyna Bakowska.

Our Latest Issue